ArticlebioRxiv : the preprint server for biology2025
Propionate metabolism dysregulation promotes drug-tolerant persister cell survival in non-small cell lung cancer.
Bobak Parang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.